Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670356 · ClinicalTrials.gov registry record · NA
Study Comparing Fish Oil and Krill Oil
A NA study, sponsored by Tufts University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02670356 is a NA study that was terminated before completion, run by Tufts University. The registered enrollment target is 2 participants.
The verdict
NCT02670356, a NA study, was terminated before completion, sponsored by Tufts University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids found in fish oil and in krill oil. The purpose of this study is to compare the effects of the recommended dose of a fish oil supplement (Omax3 4:1 EPA:DHA; recommended daily dose 1650 mg - totaling 1500 mg EPA+DHA) and a krill oil supplement (MegaRed; recommended daily dose 300 mg - totaling 74 mg EPA+DHA) on omega-3 index, plasma biomarkers of inflammation and inflammatory cell activation, and plasma lipid levels in subjects with metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT Fish oil
- DIETARY_SUPPLEMENT Krill oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02670356
The ClinicalTrials.gov registry entry for NCT02670356 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fish oil is the first listed.
NCT02670356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02670356 about?
NCT02670356 is a clinical study titled "Study Comparing Fish Oil and Krill Oil". Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids found in fish oil and in krill oil. The purpose of this study is to compare the effects of the recommended dose of a fish oil supplement (Omax3 4:1 EPA:DHA; recommended daily dose 1650 mg - totaling 1500 mg EPA+DHA) a...
What is the current status of trial NCT02670356?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2015-10. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02670356?
The interventions under investigation include: Fish oil (DIETARY_SUPPLEMENT), Krill oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02670356?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.